New drug IDE574 enters human trials for Hard-to-Treat cancers
NCT ID NCT07540572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called IDE574 in people with advanced solid tumors or a specific type of breast cancer (ER+, HER2-). The drug targets two enzymes that help cancer cells grow. The study has two parts: first, testing IDE574 alone in various cancers; second, combining it with another drug (fulvestrant) for breast cancer. About 160 participants will join to check safety, side effects, and whether the drug shrinks tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CANCER (CRPC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Florida Clinical Trials Group
RECRUITINGPlantation, Florida, 33322, United States
-
NEXT Texas LLC - Austin
RECRUITINGAustin, Texas, 78758, United States
-
NEXT Texas LLC - Dallas
RECRUITINGDallas, Texas, 75039, United States
-
NEXT Texas LLC - Houston
RECRUITINGHouston, Texas, 77054, United States
-
NEXT Texas LLC - San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
START Astera, LLC
RECRUITINGEast Brunswick, New Jersey, 08816, United States
Contact Email: •••••@•••••
-
START Dallas Fort Worth, LLC
RECRUITINGFort Worth, Texas, 76104, United States
Contact Email: •••••@•••••
-
START Mountain Region, LLC
RECRUITINGWest Valley City, Utah, 84119, United States
Contact Email: •••••@•••••
-
START New York Long Island, LLC
RECRUITINGLake Success, New York, 11042, United States
Contact Email: •••••@•••••
-
Start San Antonio, LLC
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo tame resistant prostate cancer?
- Can a Direct-to-Tumor chemo blast halt advanced lung cancer?
- Smart patch and app aim to boost lung recovery after cancer surgery
- Targeted drug LDK378 takes aim at rare ROS1-driven lung cancer
- Custom-Made vaccine aims to stop lung cancer recurrence
- Old drug, new hope: niclosamide combo targets resistant prostate cancer